The Goldman Sachs Group upgraded shares of Hoya (OTCMKTS:HOCPY – Free Report) from a hold rating to a strong-buy rating in a research report sent to investors on Wednesday,Zacks.com reports.
Separately, Erste Group Bank raised Hoya from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 23rd.
Get Our Latest Analysis on HOCPY
Hoya Price Performance
Hoya (OTCMKTS:HOCPY – Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The technology company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $0.99 by ($0.01). Hoya had a return on equity of 20.43% and a net margin of 23.22%. The business had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.50 billion. On average, sell-side analysts expect that Hoya will post 3.66 earnings per share for the current fiscal year.
Hoya Company Profile
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Featured Articles
- Five stocks we like better than Hoya
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Stocks Flying Under the S&P 500 Radar
- Best Energy Stocks – Energy Stocks to Buy Now
- Qualcomm’s Next Gear: A Growth Story Wall Street Might Be Missing
- How to Plot Fibonacci Price Inflection Levels
- 3 Cloud Build-Out Stocks Behind the AI Infrastructure Boom
Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.